AcuraStem harnesses human, patient-specific in vitro cell models and assays to develop cures and improve diagnoses in disorders of the CNS.
AcuraStem is a startup company that was formed in 2016 to create an innovative precision medicine platform. They are a team of PhDs, professors, tech entrepreneurs, and successful drug company veterans employing the latest scientific breakthroughs to address one of the most challenging, but they believe tractable, health problems of their time —Amyotrophic Lateral Sclerosis (ALS).AcuraStem harnesses advanced cellular reprogramming and artificial intelligence technologies to transform the standard of care for neurodegenerative diseases through patient-specific treatment.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 25, 2021 | Grant | $1M | 1 | Congressionally Directed Medical Research Programs | — | Detail |
Nov 8, 2019 | Convertable Note | $1M | 1 | Keiretsu Forum | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Congressionally Directed Medical Research Programs | Yes | Grant |
Keiretsu Forum | Yes | Convertable Note |